Evidence map›Paper›PMID 41851605›Full record

ArticleThe International journal of artificial organs2026

Cross-shaped nanoporous poly(methyl methacrylate) fibers for selective adsorption of β

Hiroaki Fujieda, Tomoaki Osuka, Masaru Nakada, Junko Kanda, Tatsuya Kishikawa, Hirokazu Sakaguchi, Masaki Fujita, Masahiro Osabe, Toru Sugata, Hiroyuki Sugaya and 1 more

Abstract read
In one paragraph

Article in The International journal of artificial organs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hiroaki FujiedaToray Industries, Inc., Advanced Materials Research Laboratories, Otsu, Shiga, Japan.ORCID 0009-0002-8469-5593
Tomoaki OsukaToray Industries, Inc., Advanced Materials Research Laboratories, Otsu, Shiga, Japan.
Masaru NakadaToray Research Center Inc, Research and Development Planning Department, Otsu, Shiga, Japan.ORCID 0000-0002-0483-3574
Junko KandaToray Research Center Inc, Research and Development Planning Department, Otsu, Shiga, Japan.
Tatsuya KishikawaToray Industries, Inc., Advanced Materials Research Laboratories, Otsu, Shiga, Japan.
Hirokazu SakaguchiToray Industries, Inc., Advanced Materials Research Laboratories, Otsu, Shiga, Japan.
Masaki FujitaToray Industries, Inc., Advanced Materials Research Laboratories, Otsu, Shiga, Japan.
Masahiro OsabeToray Industries, Inc., Medical Devices Technical Department, Okazaki, Aichi, Japan.
Toru SugataToray Medical Co Ltd, Blood Purification Division, Chuo, Tokyo, Japan.
Hiroyuki SugayaToray Industries, Inc., Otsu, Shiga, Japan.
Yoshiyuki UenoToray Industries, Inc., Advanced Materials Research Laboratories, Otsu, Shiga, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDialysis-related amyloidosis (DRA) is a serious complication in chronic kidney disease patients on long-term dialysis, caused by β

objectivesTo develop and evaluate stereocomplex poly(methyl methacrylate) (PMMA) adsorbent fibers with optimized cross-sectional and nanoporous structures for efficient, selective β

methodsStructured PMMA fibers were fabricated via dry-wet spinning. The adsorption performance of optimized fibers was evaluated with serum containing β

resultsFibers with 12-15 nm pores exhibited maximal β

conclusionsOptimized cross-shaped PMMA fibers enable efficient, selective β

Indexed as

Amyloidosisbeta 2-MicroglobulinNanoporesPolymethyl MethacrylateRenal DialysisAdsorptionHumansMicroscopy, Electron, ScanningMolecular WeightPorosityRenal Insufficiency, Chronicbeta 2-MicroglobulinPolymethyl Methacrylateadsorbent fibersblood purificationDialysis-related amyloidosishemoperfusionpolymethylmethacrylatepressure lossprotein adsorption

Identifiers

PMID41851605
PMCPMC13279978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.